Sartans, angiotensin II receptor antagonists, can induce psoriasis
Identifieur interne : 000034 ( France/Analysis ); précédent : 000033; suivant : 000035Sartans, angiotensin II receptor antagonists, can induce psoriasis
Auteurs : C. Marquart-Elbaz [France] ; E. Grosshans [France] ; M. Alt [France] ; D. Lipsker [France]Source :
- British Journal of Dermatology [ 0007-0963 ] ; 2002-09.
English descriptors
- Teeft :
- Acad dermatol, Adaptive immunity, Allergen, Allergic contact dermatitis, Angiotensin, Apoptosis, Apoptotic cells, Arch dermatol, Asthmatic patients, Atrophoderma, Autosomal recessive inheritance, Basal, Basal cell carcinoma, Basal cell carcinomas, Basiliximab, Biopsy, Blood transfusion, Bone marrow, Bone pain, Book deals, Book reviews, Bowel, Bowel disease, British association, British journal, British skin foundation, Bystander, Candesartan cilexetil, Carcinoma, Cardiac abnormalities, Case report, Cell death, Cell markers, Cell precursor, Central role, Chain gene, Chemical allergen, Chemical allergens, Chronic trauma, Clin, Clinical features, Clinical investigation, Clinicopathologic study, Commonest skin cancer, Congenital, Congenital ichthyosis, Contact dermatitis, Correspondence figure, Creatinine clearance, Crmo, Cutaneous, Cutaneous lesions, Cyclosporin, Cytokine, Cytokine signals, Cytotoxic molecules, Danger hypothesis, Danger model, Danger signals, Dermatitis, Dermatol, Dermatol surg oncol, Dermatologist, Dermatology, Differential diagnosis, Docetaxel, Dramatic response, Drug compatibility, Drug intake, Drug reaction, Drug reactions, Eosin staining, Epidermal, Erosive, Erosive vulvovaginal lichen planus, Extensor surfaces, Family history, Fatal hyalohyphomycosis, Flow cytometric analysis, Focal hypogranulosis, Follicular, Follicular atrophoderma, Foreign antigen, Full blood cell count, Functional subpopulations, Fungal melanonychia, Fusarium, Fusarium onychomycosis, Fusarium oxysporum, Fusarium solani, Genodermatosis, Gold particles, Granulocytic, Granulocytic sarcoma, Granulocytic sarcomas, Great toenails, Haematopoietic neoplasms, Happle syndrome, Host resistance, Hypotrichosis, Ichthyosis, Ichthyosis vulgaris, Ichthyotic skin, Imiquimod, Immune, Immune response, Immune system, Immunohistochemical staining, Immunol, Important role, Inheritance pattern, Initial presentation, Intralesional corticosteroids, Introductory section, Irregular diameter, Keratinocytes, Lactophenol cotton, Langerhans, Langerhans cell migration, Langerhans cells, Large part, Lesion, Leukaemia, Leukaemia cutis, Lichen, Local wound therapy, Localized, Lower extremities, Lower right, Lymph, Lymph nodes, Lymphoma, Major improvement, Malignant, Malignant melanoma, Mechanical injury, Melanoma, Metastasis, Metastatic, Metastatic skin area, Monoclonal antibody, Montelukast, Montelukast therapy, Mouse skin, Multifocal, Multifocal osteomyelitis, Myeloid, Myeloid cell markers, Myeloid precursor, Nail, Nail unit, Nailfold capillaroscopy, Natural killer, Ndings, Neural cell adhesion molecule, Nimesulide, Node, Normal range, Nuclear accumulation, Onychomycosis, Oral prednisolone, Oral prednisone, Oral sulphasalazine, Oral terbinafine, Osteomyelitis, Other cytokines, Other signals, Paclitaxel, Palmoplantar, Palmoplantar keratoderma, Palmoplantar pustular psoriasis, Patch testing, Pediatr dermatol, Pigmentation disorders, Planus, Platelet, Platelet count, Positive staining, Positive tunel staining, Precursor, Professional radiodermatitis, Psoriasis, Pustular, Pustular psoriasis, Pustule, Pustuloderma, Pyoderma gangrenosum, Rare case, Receptor, References figure, Regional lymph nodes, Santa cruz biotechnology, Sarcoma, Sartan, Sartan treatment, Sartans, Scalp hair, Second report, Sensitization, Severe thrombocytopenia, Skin biopsies, Skin biopsy, Skin disorders, Skin involvement, Skin irritation, Skin lesions, Skin metastases, Skin sensitization, Solani, Successful treatment, Syndrome, Systemic vasculitis, Tacrolimus, Taipei, Teledermatology, Teledermatology service, Terminal deoxynucleotidyl deoxyuridine triphosphate nick, Therapeutic class, Thrombocytopenia, Time course, Tissue remodelling, Tissue staining, Toenail, Topical, Topical application, Topical cyclosporin, Topical imiquimod, Topical imiquimod treatment, Topical tacrolimus, Topical treatment, Toxic pustuloderma, Transient myalgia, Trauma, Tumour, Tumour cells, Tumour necrosis, Tunel, Tunel staining, Ultrasound imaging, University hospital, Upper right, Viral infection, Vulval, Vulval mucosa, Western blot analysis, Wire brush, Woolly, Woolly hair, Wooly hair, Wound edge.
Url:
DOI: 10.1046/j.1365-2133.2002.48848.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E36
- to stream Istex, to step Curation: 000D66
- to stream Istex, to step Checkpoint: 000A27
- to stream Main, to step Merge: 000C36
- to stream Main, to step Curation: 000C35
- to stream Main, to step Exploration: 000C35
- to stream France, to step Extraction: 000034
Links to Exploration step
ISTEX:8B634A42F2AF12C12D3DC04AFCDA53336AC6B5F3Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sartans, angiotensin II receptor antagonists, can induce psoriasis</title>
<author><name sortKey="Marquart Lbaz, C" sort="Marquart Lbaz, C" uniqKey="Marquart Lbaz C" first="C." last="Marquart-Elbaz">C. Marquart-Elbaz</name>
</author>
<author><name sortKey="Grosshans, E" sort="Grosshans, E" uniqKey="Grosshans E" first="E." last="Grosshans">E. Grosshans</name>
</author>
<author><name sortKey="Alt, M" sort="Alt, M" uniqKey="Alt M" first="M." last="Alt">M. Alt</name>
</author>
<author><name sortKey="Lipsker, D" sort="Lipsker, D" uniqKey="Lipsker D" first="D." last="Lipsker">D. Lipsker</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8B634A42F2AF12C12D3DC04AFCDA53336AC6B5F3</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1046/j.1365-2133.2002.48848.x</idno>
<idno type="url">https://api.istex.fr/document/8B634A42F2AF12C12D3DC04AFCDA53336AC6B5F3/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E36</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E36</idno>
<idno type="wicri:Area/Istex/Curation">000D66</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A27</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A27</idno>
<idno type="wicri:doubleKey">0007-0963:2002:Marquart Lbaz C:sartans:angiotensin:ii</idno>
<idno type="wicri:Area/Main/Merge">000C36</idno>
<idno type="wicri:Area/Main/Curation">000C35</idno>
<idno type="wicri:Area/Main/Exploration">000C35</idno>
<idno type="wicri:Area/France/Extraction">000034</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sartans, angiotensin II receptor antagonists, can induce psoriasis</title>
<author><name sortKey="Marquart Lbaz, C" sort="Marquart Lbaz, C" uniqKey="Marquart Lbaz C" first="C." last="Marquart-Elbaz">C. Marquart-Elbaz</name>
<affiliation wicri:level="3"><country wicri:rule="url">France</country>
<wicri:regionArea>Clinique Dermatologique and *Centre de Pharmacovigilance, Hôpitaux Universitaires de Strasbourg, 1, Place de L'hôpital, 67091 Strasbourg cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grosshans, E" sort="Grosshans, E" uniqKey="Grosshans E" first="E." last="Grosshans">E. Grosshans</name>
<affiliation wicri:level="3"><country wicri:rule="url">France</country>
<wicri:regionArea>Clinique Dermatologique and *Centre de Pharmacovigilance, Hôpitaux Universitaires de Strasbourg, 1, Place de L'hôpital, 67091 Strasbourg cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alt, M" sort="Alt, M" uniqKey="Alt M" first="M." last="Alt">M. Alt</name>
<affiliation wicri:level="3"><country wicri:rule="url">France</country>
<wicri:regionArea>Clinique Dermatologique and *Centre de Pharmacovigilance, Hôpitaux Universitaires de Strasbourg, 1, Place de L'hôpital, 67091 Strasbourg cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lipsker, D" sort="Lipsker, D" uniqKey="Lipsker D" first="D." last="Lipsker">D. Lipsker</name>
<affiliation wicri:level="3"><country wicri:rule="url">France</country>
<wicri:regionArea>Clinique Dermatologique and *Centre de Pharmacovigilance, Hôpitaux Universitaires de Strasbourg, 1, Place de L'hôpital, 67091 Strasbourg cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">British Journal of Dermatology</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint><publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
<biblScope unit="volume">147</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="617">617</biblScope>
<biblScope unit="page" to="618">618</biblScope>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
<idno type="istex">8B634A42F2AF12C12D3DC04AFCDA53336AC6B5F3</idno>
<idno type="DOI">10.1046/j.1365-2133.2002.48848.x</idno>
<idno type="ArticleID">BJD4884_8</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad dermatol</term>
<term>Adaptive immunity</term>
<term>Allergen</term>
<term>Allergic contact dermatitis</term>
<term>Angiotensin</term>
<term>Apoptosis</term>
<term>Apoptotic cells</term>
<term>Arch dermatol</term>
<term>Asthmatic patients</term>
<term>Atrophoderma</term>
<term>Autosomal recessive inheritance</term>
<term>Basal</term>
<term>Basal cell carcinoma</term>
<term>Basal cell carcinomas</term>
<term>Basiliximab</term>
<term>Biopsy</term>
<term>Blood transfusion</term>
<term>Bone marrow</term>
<term>Bone pain</term>
<term>Book deals</term>
<term>Book reviews</term>
<term>Bowel</term>
<term>Bowel disease</term>
<term>British association</term>
<term>British journal</term>
<term>British skin foundation</term>
<term>Bystander</term>
<term>Candesartan cilexetil</term>
<term>Carcinoma</term>
<term>Cardiac abnormalities</term>
<term>Case report</term>
<term>Cell death</term>
<term>Cell markers</term>
<term>Cell precursor</term>
<term>Central role</term>
<term>Chain gene</term>
<term>Chemical allergen</term>
<term>Chemical allergens</term>
<term>Chronic trauma</term>
<term>Clin</term>
<term>Clinical features</term>
<term>Clinical investigation</term>
<term>Clinicopathologic study</term>
<term>Commonest skin cancer</term>
<term>Congenital</term>
<term>Congenital ichthyosis</term>
<term>Contact dermatitis</term>
<term>Correspondence figure</term>
<term>Creatinine clearance</term>
<term>Crmo</term>
<term>Cutaneous</term>
<term>Cutaneous lesions</term>
<term>Cyclosporin</term>
<term>Cytokine</term>
<term>Cytokine signals</term>
<term>Cytotoxic molecules</term>
<term>Danger hypothesis</term>
<term>Danger model</term>
<term>Danger signals</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatol surg oncol</term>
<term>Dermatologist</term>
<term>Dermatology</term>
<term>Differential diagnosis</term>
<term>Docetaxel</term>
<term>Dramatic response</term>
<term>Drug compatibility</term>
<term>Drug intake</term>
<term>Drug reaction</term>
<term>Drug reactions</term>
<term>Eosin staining</term>
<term>Epidermal</term>
<term>Erosive</term>
<term>Erosive vulvovaginal lichen planus</term>
<term>Extensor surfaces</term>
<term>Family history</term>
<term>Fatal hyalohyphomycosis</term>
<term>Flow cytometric analysis</term>
<term>Focal hypogranulosis</term>
<term>Follicular</term>
<term>Follicular atrophoderma</term>
<term>Foreign antigen</term>
<term>Full blood cell count</term>
<term>Functional subpopulations</term>
<term>Fungal melanonychia</term>
<term>Fusarium</term>
<term>Fusarium onychomycosis</term>
<term>Fusarium oxysporum</term>
<term>Fusarium solani</term>
<term>Genodermatosis</term>
<term>Gold particles</term>
<term>Granulocytic</term>
<term>Granulocytic sarcoma</term>
<term>Granulocytic sarcomas</term>
<term>Great toenails</term>
<term>Haematopoietic neoplasms</term>
<term>Happle syndrome</term>
<term>Host resistance</term>
<term>Hypotrichosis</term>
<term>Ichthyosis</term>
<term>Ichthyosis vulgaris</term>
<term>Ichthyotic skin</term>
<term>Imiquimod</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immune system</term>
<term>Immunohistochemical staining</term>
<term>Immunol</term>
<term>Important role</term>
<term>Inheritance pattern</term>
<term>Initial presentation</term>
<term>Intralesional corticosteroids</term>
<term>Introductory section</term>
<term>Irregular diameter</term>
<term>Keratinocytes</term>
<term>Lactophenol cotton</term>
<term>Langerhans</term>
<term>Langerhans cell migration</term>
<term>Langerhans cells</term>
<term>Large part</term>
<term>Lesion</term>
<term>Leukaemia</term>
<term>Leukaemia cutis</term>
<term>Lichen</term>
<term>Local wound therapy</term>
<term>Localized</term>
<term>Lower extremities</term>
<term>Lower right</term>
<term>Lymph</term>
<term>Lymph nodes</term>
<term>Lymphoma</term>
<term>Major improvement</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Mechanical injury</term>
<term>Melanoma</term>
<term>Metastasis</term>
<term>Metastatic</term>
<term>Metastatic skin area</term>
<term>Monoclonal antibody</term>
<term>Montelukast</term>
<term>Montelukast therapy</term>
<term>Mouse skin</term>
<term>Multifocal</term>
<term>Multifocal osteomyelitis</term>
<term>Myeloid</term>
<term>Myeloid cell markers</term>
<term>Myeloid precursor</term>
<term>Nail</term>
<term>Nail unit</term>
<term>Nailfold capillaroscopy</term>
<term>Natural killer</term>
<term>Ndings</term>
<term>Neural cell adhesion molecule</term>
<term>Nimesulide</term>
<term>Node</term>
<term>Normal range</term>
<term>Nuclear accumulation</term>
<term>Onychomycosis</term>
<term>Oral prednisolone</term>
<term>Oral prednisone</term>
<term>Oral sulphasalazine</term>
<term>Oral terbinafine</term>
<term>Osteomyelitis</term>
<term>Other cytokines</term>
<term>Other signals</term>
<term>Paclitaxel</term>
<term>Palmoplantar</term>
<term>Palmoplantar keratoderma</term>
<term>Palmoplantar pustular psoriasis</term>
<term>Patch testing</term>
<term>Pediatr dermatol</term>
<term>Pigmentation disorders</term>
<term>Planus</term>
<term>Platelet</term>
<term>Platelet count</term>
<term>Positive staining</term>
<term>Positive tunel staining</term>
<term>Precursor</term>
<term>Professional radiodermatitis</term>
<term>Psoriasis</term>
<term>Pustular</term>
<term>Pustular psoriasis</term>
<term>Pustule</term>
<term>Pustuloderma</term>
<term>Pyoderma gangrenosum</term>
<term>Rare case</term>
<term>Receptor</term>
<term>References figure</term>
<term>Regional lymph nodes</term>
<term>Santa cruz biotechnology</term>
<term>Sarcoma</term>
<term>Sartan</term>
<term>Sartan treatment</term>
<term>Sartans</term>
<term>Scalp hair</term>
<term>Second report</term>
<term>Sensitization</term>
<term>Severe thrombocytopenia</term>
<term>Skin biopsies</term>
<term>Skin biopsy</term>
<term>Skin disorders</term>
<term>Skin involvement</term>
<term>Skin irritation</term>
<term>Skin lesions</term>
<term>Skin metastases</term>
<term>Skin sensitization</term>
<term>Solani</term>
<term>Successful treatment</term>
<term>Syndrome</term>
<term>Systemic vasculitis</term>
<term>Tacrolimus</term>
<term>Taipei</term>
<term>Teledermatology</term>
<term>Teledermatology service</term>
<term>Terminal deoxynucleotidyl deoxyuridine triphosphate nick</term>
<term>Therapeutic class</term>
<term>Thrombocytopenia</term>
<term>Time course</term>
<term>Tissue remodelling</term>
<term>Tissue staining</term>
<term>Toenail</term>
<term>Topical</term>
<term>Topical application</term>
<term>Topical cyclosporin</term>
<term>Topical imiquimod</term>
<term>Topical imiquimod treatment</term>
<term>Topical tacrolimus</term>
<term>Topical treatment</term>
<term>Toxic pustuloderma</term>
<term>Transient myalgia</term>
<term>Trauma</term>
<term>Tumour</term>
<term>Tumour cells</term>
<term>Tumour necrosis</term>
<term>Tunel</term>
<term>Tunel staining</term>
<term>Ultrasound imaging</term>
<term>University hospital</term>
<term>Upper right</term>
<term>Viral infection</term>
<term>Vulval</term>
<term>Vulval mucosa</term>
<term>Western blot analysis</term>
<term>Wire brush</term>
<term>Woolly</term>
<term>Woolly hair</term>
<term>Wooly hair</term>
<term>Wound edge</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Alsace (région administrative)</li>
<li>Grand Est</li>
</region>
<settlement><li>Strasbourg</li>
</settlement>
</list>
<tree><country name="France"><region name="Grand Est"><name sortKey="Marquart Lbaz, C" sort="Marquart Lbaz, C" uniqKey="Marquart Lbaz C" first="C." last="Marquart-Elbaz">C. Marquart-Elbaz</name>
</region>
<name sortKey="Alt, M" sort="Alt, M" uniqKey="Alt M" first="M." last="Alt">M. Alt</name>
<name sortKey="Grosshans, E" sort="Grosshans, E" uniqKey="Grosshans E" first="E." last="Grosshans">E. Grosshans</name>
<name sortKey="Lipsker, D" sort="Lipsker, D" uniqKey="Lipsker D" first="D." last="Lipsker">D. Lipsker</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000034 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000034 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sarre |area= MusicSarreV3 |flux= France |étape= Analysis |type= RBID |clé= ISTEX:8B634A42F2AF12C12D3DC04AFCDA53336AC6B5F3 |texte= Sartans, angiotensin II receptor antagonists, can induce psoriasis }}
This area was generated with Dilib version V0.6.33. |